{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:17:25Z","timestamp":1793755045414,"version":"4.6.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Health Econ"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1007\/s10198-013-0537-5","type":"journal-article","created":{"date-parts":[[2013,11,30]],"date-time":"2013-11-30T09:12:46Z","timestamp":1385802766000},"page":"953-966","source":"Crossref","is-referenced-by-count":26,"title":["Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I)"],"prefix":"10.1007","volume":"15","author":[{"given":"Uwe K.","family":"Zettl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Henze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ute","family":"Essner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Flachenecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,1]]},"reference":[{"key":"537_CR1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/bmj.280.6208.184-d","volume":"280","author":"JH Millar","year":"1980","unstructured":"Millar, J.H.: Multiple sclerosis. Br. Med. J. 280, 184\u2013185 (1980)","journal-title":"Br. Med. J."},{"key":"537_CR2","unstructured":"Nicholas, R., Rashid, W.: Multiple sclerosis. Clin. Evid. pii: 1202 (2012). Accessed 10 Feb 2012"},{"key":"537_CR3","volume-title":"McAlpine\u2019s multiple sclerosis","author":"I McDonald","year":"2006","unstructured":"McDonald, I., Compston, A.: The symptoms and signs of multiple scleroses. In: Compston, A., Ebers, G., Lassmann, H., McDonald, I., Matthews, W.B., Wekerle, H. (eds.) McAlpine\u2019s multiple sclerosis, 4th edn. Elsevier, Philadelphia (2006)","edition":"4"},{"key":"537_CR4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00401-012-0953-0","volume":"123","author":"J Antel","year":"2012","unstructured":"Antel, J., Antel, S., Caramanos, Z., Arnold, D.L., Kuhlmann, T.: Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? Acta Neuropathol. 123, 627\u2013638 (2012)","journal-title":"Acta Neuropathol."},{"key":"537_CR5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/157015911796557911","volume":"9","author":"I Loma","year":"2011","unstructured":"Loma, I., Heyman, R.: Multiple sclerosis: pathogenesis and treatment. Curr. Neuropharmacol. 9, 409\u2013416 (2011)","journal-title":"Curr. Neuropharmacol."},{"issue":"Suppl","key":"537_CR6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ana.410360704","volume":"36","author":"BG Weinshenker","year":"1994","unstructured":"Weinshenker, B.G.: Natural history of multiple sclerosis. Ann. Neurol. 36(Suppl), 6\u201311 (1994)","journal-title":"Ann. Neurol."},{"key":"537_CR7","first-page":"948","volume":"40","author":"BK Tsang","year":"2011","unstructured":"Tsang, B.K.: Macdonell. Multiple sclerosis- diagnosis, management and prognosis. Aust. Fam. Physician. 40, 948\u2013955 (2011)","journal-title":"Aust. Fam. Physician."},{"key":"537_CR8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bmj.332.7540.525","volume":"332","author":"TJ Murray","year":"2006","unstructured":"Murray, T.J.: Diagnosis and treatment of multiple sclerosis. BMJ 332, 525\u2013527 (2006)","journal-title":"BMJ"},{"key":"537_CR9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0021-9681(86)90052-4","volume":"39","author":"AC Harper","year":"1986","unstructured":"Harper, A.C., Harper, D.A., Chambers, L.W., Cino, P.M., Singer, J.: An epidemiological description of physical, social and psychological problems in multiple sclerosis. J. Chronic Dis. 39, 305\u2013310 (1986)","journal-title":"J. Chronic Dis."},{"key":"537_CR10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00900502","volume":"243","author":"GJ Lankhorst","year":"1996","unstructured":"Lankhorst, G.J., Jelles, F., Smits, R.C., Polman, C.H., Kuik, D.J., Pfennings, L.E., Cohen, L., van der Ploeg, H.M., Ketelaer, P., Vleugels, L.: Quality of life in multiple sclerosis: the disability and impact profile (DIP). J. Neurol. 243, 469\u2013474 (1996)","journal-title":"J. Neurol."},{"key":"537_CR11","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archneur.1992.00530360035014","volume":"49","author":"RA Rudick","year":"1992","unstructured":"Rudick, R.A., Miller, D., Clough, J.D., Gragg, L.A., Farmer, R.G.: Quality of life in multiple sclerosis. Comparison with inflammatory bowel disease and rheumatoid arthritis. Arch. Neurol. 49, 1237\u20131242 (1992)","journal-title":"Arch. Neurol."},{"key":"537_CR12","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1212\/WNL.41.5.692","volume":"41","author":"SM Rao","year":"1991","unstructured":"Rao, S.M., Leo, G.J., Ellington, L., Nauertz, T., Bernardin, L., Unverzagt, F.: Cognitive dysfunction in multiple sclerosis. II. Impact on employment and social functioning. Neurology. 41, 692\u2013696 (1991)","journal-title":"Neurology."},{"key":"537_CR13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","volume":"10","author":"MA Rizzo","year":"2004","unstructured":"Rizzo, M.A., Hadjimichael, O.C., Preiningerova, J., Vollmer, T.L.: Prevalence and treatment of spasticity reported by multiple sclerosis patients. Mult. Scler. 10, 589\u2013595 (2004)","journal-title":"Mult. Scler."},{"key":"537_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta7400","volume":"7","author":"S Beard","year":"2003","unstructured":"Beard, S., Hunn, A., Wight, J.: Treatments for spasticity and pain in multiple sclerosis: a systematic review. Health Technol. Assess. 7, 1\u2013111 (2003)","journal-title":"Health Technol. Assess."},{"key":"537_CR15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1177\/0888439002250449","volume":"17","author":"MP Barnes","year":"2003","unstructured":"Barnes, M.P., Kent, R.M., Semlyen, J.K., McMullen, K.M.: Spasticity in multiple sclerosis. Neurorehabil. Neural. Repair. 17, 66\u201370 (2003)","journal-title":"Neurorehabil. Neural. Repair."},{"key":"537_CR16","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1212\/WNL.30.12.1303","volume":"30","author":"JW Lance","year":"1980","unstructured":"Lance, J.W.: The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology. 30, 1303\u20131313 (1980)","journal-title":"Neurology."},{"key":"537_CR17","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s12325-009-0082-x","volume":"26","author":"HL Zwibel","year":"2009","unstructured":"Zwibel, H.L.: Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. Adv. Ther. 26, 1043\u20131057 (2009)","journal-title":"Adv. Ther."},{"key":"537_CR18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11910-011-0214-y","volume":"11","author":"MH Cameron","year":"2011","unstructured":"Cameron, M.H., Wagner, J.M.: Gait abnormalities in multiple sclerosis: pathogenesis, evaluation, and advances in treatment. Curr. Neurol. Neurosci. Rep. 11, 507\u2013515 (2011)","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"537_CR19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.clinthera.2006.04.005","volume":"28","author":"HJ Crayton","year":"2006","unstructured":"Crayton, H.J., Rossman, H.S.: Managing the symptoms of multiple sclerosis: a multimodal approach. Clin. Ther. 28, 445\u2013460 (2006)","journal-title":"Clin. Ther."},{"key":"537_CR20","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/brain\/awh675","volume":"129","author":"JC Hobart","year":"2006","unstructured":"Hobart, J.C., Riazi, A., Thompson, A.J., Styles, I.M., Ingram, W., Vickery, P.J., Warner, M., Fox, P.J., Zajicek, J.P.: Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88). Brain 129, 224\u2013234 (2006)","journal-title":"Brain"},{"issue":"Suppl 5","key":"537_CR21","first-page":"139","volume":"17","author":"HL Zwibel","year":"2011","unstructured":"Zwibel, H.L., Smrtka, J.: Improving quality of life in multiple sclerosis: an unmet need. Am. J. Manag. Care. 17(Suppl 5), 139\u2013145 (2011)","journal-title":"Am. J. Manag. Care."},{"key":"537_CR22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1682\/JRRD.2009.07.0096","volume":"47","author":"A Souza","year":"2010","unstructured":"Souza, A., Kelleher, A., Cooper, R., Cooper, R.A., Iezzoni, L.I., Collins, D.M.: Multiple sclerosis and mobility-related assistive technology: systematic review of literature. J. Rehabil. Res. Dev. 47, 213\u2013223 (2010)","journal-title":"J. Rehabil. Res. Dev."},{"key":"537_CR23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000095699","volume":"56","author":"T Henze","year":"2006","unstructured":"Henze, T., Rieckmann, P., Toyka, K.V.: Symptomatic treatment of multiple sclerosis. Eur. Neurol. 56, 78\u2013105 (2006)","journal-title":"Eur. Neurol."},{"key":"537_CR24","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2340\/16501977-0811","volume":"43","author":"T Rekand","year":"2011","unstructured":"Rekand, T., Gr\u00f8nning, M.: Treatment of spasticity related to multiple sclerosis with intrathecal baclofen: a long-term follow-up. J. Rehabil. Med. 43, 511\u2013514 (2011)","journal-title":"J. Rehabil. Med."},{"key":"537_CR25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1191\/1352458506ms1232sr","volume":"12","author":"D Ben Smail","year":"2006","unstructured":"Ben Smail, D., Peskine, A., Roche, N., Mailhan, L., Thi\u00e9baut, I., Bussel, B.: Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients. Mult. Scler. 12, 101\u2013103 (2006)","journal-title":"Mult. Scler."},{"key":"537_CR26","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM198906083202303","volume":"320","author":"RD Penn","year":"1989","unstructured":"Penn, R.D., Savoy, S.M., Corcos, D., Latash, M., Gottlieb, G., Parke, B., Kroin, J.S.: Intrathecal baclofen for severe spinal spasticity. N. Engl. J. Med. 320, 1517\u20131521 (1989)","journal-title":"N. Engl. J. Med."},{"key":"537_CR27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1001\/archneur.1977.00500210024001","volume":"34","author":"BA Sachais","year":"1977","unstructured":"Sachais, B.A., Logue, J.N., Carey, M.S.: Baclofen, a new antispastic drug. A controlled, multicenter trial in patients with multiple sclerosis. Arch. Neurol. 34, 22\u201328 (1977)","journal-title":"Arch. Neurol."},{"key":"537_CR28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.4.5778.15","volume":"4","author":"P Hudgson","year":"1971","unstructured":"Hudgson, P., Weightman, D.: Baclofen in the treatment of spasticity. Br. Med. J. 4, 15\u201317 (1971)","journal-title":"Br. Med. J."},{"key":"537_CR29","first-page":"241","volume":"15","author":"L Groves","year":"1998","unstructured":"Groves, L., Shellenberger, M.K., Davis, C.S.: Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam. Adv. Ther. 15, 241\u2013251 (1998)","journal-title":"Adv. Ther."},{"key":"537_CR30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1017\/S0317167100038026","volume":"14","author":"Y Lapierre","year":"1987","unstructured":"Lapierre, Y., Bouchard, S., Tansey, C., Gendron, D., Barkas, W.J., Francis, G.S.: Treatment of spasticity with tizanidine in multiple sclerosis. Can. J. Neurol. Sci. 14, 513\u2013551 (1987)","journal-title":"Can. J. Neurol. Sci."},{"key":"537_CR31","doi-asserted-by":"crossref","first-page":"i26","DOI":"10.1007\/s00415-006-1106-y","volume":"253","author":"C Kabus","year":"2006","unstructured":"Kabus, C., Hecht, M., Japp, G., Jost, W.H., P\u00f6hlau, D., Stuckrad-Barre, S., Winterholler, M.: Botulinum toxin in patients with multiple sclerosis. J. Neurol. 253, i26\u2013i28 (2006)","journal-title":"J. Neurol."},{"key":"537_CR32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/(SICI)1097-4598(200002)23:2<153::AID-MUS3>3.0.CO;2-4","volume":"23","author":"MD Smyth","year":"2000","unstructured":"Smyth, M.D., Peacock, W.J.: The surgical treatment of spasticity. Muscle Nerve 23, 153\u2013163 (2000)","journal-title":"Muscle Nerve"},{"key":"537_CR33","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1586\/erp.11.6","volume":"11","author":"R Arroyo","year":"2011","unstructured":"Arroyo, R., Vila, C., Clissold, S.: Retrospective observational study of the management of multiple sclerosis patients with resistant spasticity in Spain: the \u201c5E\u201d study. Expert Rev. Pharmacoecon. Outcomes Res. 11, 205\u2013213 (2011)","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"537_CR34","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/00019053-200826100-00005","volume":"26","author":"P McCrone","year":"2008","unstructured":"McCrone, P., Heslin, M., Knapp, M., Bull, P., Thompson, A.: Multiple sclerosis in the UK: service use, costs, quality of life and disability. Pharmacoeconomics. 26, 847\u2013860 (2008)","journal-title":"Pharmacoeconomics."},{"key":"537_CR35","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01376517-200802000-00005","volume":"40","author":"M Buhse","year":"2008","unstructured":"Buhse, M.: Assessment of caregiver burden in families of persons with multiple sclerosis. J. Neurosci. Nurs. 40, 25\u201331 (2008)","journal-title":"J. Neurosci. Nurs."},{"key":"537_CR36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2165\/00019053-199915040-00007","volume":"15","author":"TJ Postma","year":"1999","unstructured":"Postma, T.J., Oenema, D., Terpstra, S., Bouma, J., Kuipers-Upmeijer, H., Staal, M.J., Middel, B.J.: Cost analysis of the treatment of severe spinal spasticity with a continuous intrathecal baclofen infusion system. Pharmacoeconomics. 15, 395\u2013404 (1999)","journal-title":"Pharmacoeconomics."},{"key":"537_CR37","unstructured":"German Society for Multiple Sclerosis. Epidemiology of MS in Germany. Available at http:\/\/www.dmsg.de\/multiple-sklerose-infos\/index.php?w3pid=ms#H\u00e4ufigkeit . Accessed on 10.10.2011"},{"key":"537_CR38","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.clinthera.2008.05.011","volume":"30","author":"JT Farrar","year":"2008","unstructured":"Farrar, J.T., Troxel, A.B., Stott, C., Duncombe, P., Jensen, M.P.: Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. Clin. Ther. 30, 974\u2013985 (2008)","journal-title":"Clin. Ther."},{"key":"537_CR39","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/1352458507082480","volume":"14","author":"P Flachenecker","year":"2008","unstructured":"Flachenecker, P., Meissner, H.: Fatigue in multiple sclerosis presenting as acute relapse: subjective and objective assessment. Mult. Scler. 14, 274\u2013277 (2008)","journal-title":"Mult. Scler."},{"key":"537_CR40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1191\/1352458504ms1056oa","volume":"10","author":"L Nicholl","year":"2004","unstructured":"Nicholl, L., Hobart, J., Dunwoody, L., Cramp, F., Lowe-Strong, A.: Measuring disability in multiple sclerosis: is the Community Dependency Index an improvement on the Barthel Index? Mult. Scler. 10, 447\u2013450 (2004)","journal-title":"Mult. Scler."},{"key":"537_CR41","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke, J.F.: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33, 1444\u20131452 (1983)","journal-title":"Neurology"},{"key":"537_CR42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol Group","year":"1990","unstructured":"Group, EuroQol: EuroQol \u2013 a new facility for the measurement of health-related quality of life. Health Policy 16, 199\u2013208 (1990)","journal-title":"Health Policy"},{"key":"537_CR43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.socscimed.2003.10.015","volume":"59","author":"D Parkin","year":"2004","unstructured":"Parkin, D., Rice, N., Jacoby, A., Doughty, J.: Use of a visual analogue scale in a daily patient diary: modelling cross-sectional time-series data on health-related quality of life. Soc. Sci. Med. 59, 351\u2013360 (2004)","journal-title":"Soc. Sci. Med."},{"key":"537_CR44","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02260859","volume":"4","author":"G Vickrey","year":"1995","unstructured":"Vickrey, G., Hays, R.D., Harooni, F., Myers, L.W., Ellison, G.W.: A health-related quality of life measure for multiple sclerosis. Qual. Life Res. 4, 187\u2013202 (1995)","journal-title":"Qual. Life Res."},{"key":"537_CR45","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.apmr.2009.09.013","volume":"91","author":"JJ Sosnoff","year":"2010","unstructured":"Sosnoff, J.J., Shin, S., Motl, R.W.: Multiple sclerosis and postural control: the role of spasticity. Arch. Phys. Med. Rehabil. 91, 93\u201399 (2010)","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"537_CR46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1191\/1352458502ms851oa","volume":"8","author":"CH Chang","year":"2002","unstructured":"Chang, C.H., Cella, D., Fern\u00e1ndez, O., Luque, G., de Castro, P., de Andr\u00e9s, C., Casanova, B., Hern\u00e1ndez, M.A., Prieto, J.M., Fern\u00e1ndez, V.E., de Ram\u00f3n, E.: Grupo Espa\u00f1ol de Calidad de Vida en Esclerosis M\u00faltiple. Quality of life in multiple sclerosis patients in Spain. Mult. Scler. 8, 527\u2013531 (2002)","journal-title":"Mult. Scler."},{"key":"537_CR47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1191\/1352458504ms967oa","volume":"10","author":"JM Morales-Gonz\u00e1les","year":"2004","unstructured":"Morales-Gonz\u00e1les, J.M., Benito-Le\u00f3n, J., Rivera-Navarro, J., Mitchell, A.J.: GEDMA Study Group. A systematic approach to analyse health-related quality of life in multiple sclerosis: the GEDMA study. Mult. Scler. 10, 47\u201354 (2004)","journal-title":"Mult. Scler."},{"key":"537_CR48","first-page":"846","volume":"69","author":"R Olgiati","year":"1988","unstructured":"Olgiati, R., Burgunder, J.M., Mumenthaler, M.: Increased energy cost of walking in multiple sclerosis: effect of spasticity, ataxia, and weakness. Arch. Phys. Med. Rehabil. 69, 846\u2013849 (1988)","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"537_CR49","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/bmj.314.7094.1580","volume":"314","author":"PM Rothwell","year":"1997","unstructured":"Rothwell, P.M., McDowell, Z., Wong, C.K., Dorman, P.J.: Doctors and patients don\u2019t agree: cross sectional study of patients\u2019 and doctors\u2019 perceptions and assessments of disability in multiple sclerosis. BMJ 314, 1580\u20131583 (1997)","journal-title":"BMJ"},{"key":"537_CR50","first-page":"186","volume":"72","author":"SP Brar","year":"1991","unstructured":"Brar, S.P., Smith, M.B., Nelson, L.M., Franklin, G.M., Cobble, N.D.: Evaluation of treatment protocols on minimal to moderate spasticity in multiple sclerosis. Arch. Phys. Med. Rehabil. 72, 186\u2013189 (1991)","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"537_CR51","first-page":"CD001332","volume":"4","author":"DT Shakespeare","year":"2001","unstructured":"Shakespeare, D.T., Boggild, M., Young, C.: Anti-spasticity agents for multiple sclerosis. Cochrane Database Syst. Rev. 4, CD001332 (2001)","journal-title":"Cochrane Database Syst. Rev."},{"key":"537_CR52","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1177\/1545968308328724","volume":"23","author":"D Bensmail","year":"2009","unstructured":"Bensmail, D., Ward, A.B., Wissel, J., Motta, F., Saltuari, L., Lissens, J., Cros, S., Beresniak, A.: Cost-effectiveness modelling of intrathecal baclofen therapy versus other interventions for disabling spasticity. Neurorehabil. Neural. Repair. 23, 546\u2013552 (2009)","journal-title":"Neurorehabil. Neural. Repair."},{"key":"537_CR53","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/135910530100600508","volume":"6","author":"P Nicolson","year":"2001","unstructured":"Nicolson, P., Anderson, P.: The psychosocial impact of spasticity-related problems for people with multiple sclerosis: a focus group study. J. Health Psychol. 6, 551\u2013567 (2001)","journal-title":"J. Health Psychol."},{"key":"537_CR54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/NPT.0b013e31822a8c40","volume":"35","author":"JJ Sosnoff","year":"2011","unstructured":"Sosnoff, J.J., Gappmaier, E., Frame, A., Motl, R.W.: Influence of spasticity on mobility and balance in persons with multiple sclerosis. J. Neurol. Phys. Ther 35, 129\u2013132 (2011)","journal-title":"J. Neurol. Phys. Ther"},{"key":"537_CR55","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11136-005-0891-6","volume":"15","author":"A Miller","year":"2006","unstructured":"Miller, A., Dishon, S.: Health-related quality of life in multiple sclerosis: the impact of disability, gender and employment status. Qual. Life Res. 15, 259\u2013271 (2006)","journal-title":"Qual. Life Res."},{"key":"537_CR56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1017\/S0317167100053403","volume":"30","author":"KD Busche","year":"2003","unstructured":"Busche, K.D., Fisk, J.D., Murray, T.J., Metz, L.M.: Short term predictors of unemployment in multiple sclerosis patients. Can. J. Neurol. Sci. 30, 137\u2013142 (2003)","journal-title":"Can. J. Neurol. Sci."},{"key":"537_CR57","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/1352458506073511","volume":"13","author":"F Patti","year":"2007","unstructured":"Patti, F., Pozzilli, C., Montanari, E., Pappalardo, A., Piazza, L., Levi, A., Onesti, E., Pesci, I.: Italian study group on quality of life in MS. Effects of education level and employment status on HRQoL in early relapsing-remitting multiple sclerosis. Mult. Scler. 13, 783\u2013791 (2007)","journal-title":"Mult. Scler."},{"key":"537_CR58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1191\/026921599677595404","volume":"13","author":"AD Pandyan","year":"1999","unstructured":"Pandyan, A.D., Johnson, G.R., Price, C.I., Curless, R.H., Barnes, M.P., Rodgers, H.: A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity. Clin. Rehabil. 13, 373\u2013383 (1999)","journal-title":"Clin. Rehabil."},{"key":"537_CR59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000331043","volume":"66","author":"JP Reese","year":"2011","unstructured":"Reese, J.P., John, A., Wienemann, G., Wellek, A., Sommer, N., Tackenberg, B., Balzer-Geldsetzer, M., Dodel, R.: Economic burden in a german cohort of patients with multiple sclerosis. Eur. Neurol. 66, 311\u2013321 (2011)","journal-title":"Eur. Neurol."},{"key":"537_CR60","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jocn.2006.08.007","volume":"14","author":"B Taylor","year":"2007","unstructured":"Taylor, B., McDonald, E., Fantino, B., Sedal, L., MacDonnell, R., Pittas, F., Groom, T., Beresniak, A.: The cost of multiple sclerosis in Australia. J. Clin. Neurosci. 14, 532\u2013539 (2007)","journal-title":"J. Clin. Neurosci."},{"key":"537_CR61","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00019053-199915030-00003","volume":"15","author":"AN Grudzinski","year":"1999","unstructured":"Grudzinski, A.N., Hakim, Z., Cox, R., Bootman, J.L.: The economics of multiple sclerosis. Distribution of costs and relationship to disease severity. Pharmaeconomics 15, 229\u2013240 (1999)","journal-title":"Pharmaeconomics"},{"key":"537_CR62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0317167100033448","volume":"25","author":"The Canadian Burden of Illness Study Group","year":"1998","unstructured":"The Canadian Burden of Illness Study Group: Burden of illness of multiple sclerosis: Part I: Cost of illness. Can. J. Neurol. Sci. 25, 23\u201330 (1998)","journal-title":"Can. J. Neurol. Sci."},{"key":"537_CR63","first-page":"46","volume":"101","author":"RP Inman","year":"1984","unstructured":"Inman, R.P.: Disability indices, the economic costs of illness, and social insurance: the case of multiple sclerosis. Acta Neurol. Scand. 101, 46\u201355 (1984)","journal-title":"Acta Neurol. Scand."},{"key":"537_CR64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.euroneuro.2011.05.001","volume":"22","author":"P Jennum","year":"2012","unstructured":"Jennum, P., Wanscher, B., Frederiksen, J., Kjellberg, J.: The socioeconomic consequences of multiple sclerosis: a controlled national study. Eur. Neuropsychopharmacol. 22, 36\u201343 (2012)","journal-title":"Eur. Neuropsychopharmacol."},{"key":"537_CR65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1468-1331.2011.03590.x","volume":"19","author":"J Olesen","year":"2012","unstructured":"Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H.U., J\u00f6nsson, B.: CDBE2010 study group; European Brain Council. The economic cost of brain disorders in Europe. Eur. J. Neurol. 19, 155\u2013162 (2012)","journal-title":"Eur. J. Neurol."},{"key":"537_CR66","doi-asserted-by":"crossref","first-page":"703","DOI":"10.18553\/jmcp.2010.16.9.703","volume":"16","author":"CV Asche","year":"2010","unstructured":"Asche, C.V., Singer, M.S., Jhaveri, M., Chung, H., Miller, A.: All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States. J. Manag. Care Pharm. 16, 703\u2013712 (2010)","journal-title":"J. Manag. Care Pharm."},{"issue":"Suppl 2","key":"537_CR67","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10198-006-0384-8","volume":"7","author":"G Kobelt","year":"2006","unstructured":"Kobelt, G., Berg, J., Lindgren, P., Elias, W.G., Flachenecker, P., Freidel, M., K\u00f6nig, N., Limmroth, V., Straube, E.: Costs and quality of life of multiple sclerosis in Germany. Eur. J. Health Econ. 7(Suppl 2), 34\u201344 (2006)","journal-title":"Eur. J. Health Econ."},{"key":"537_CR68","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1177\/135245859800400504","volume":"4","author":"K Whetten-Goldstein","year":"1998","unstructured":"Whetten-Goldstein, K., Sloan, F.A., Goldstein, L.B., Kulas, E.D.: A comprehensive assessment of the cost of multiple sclerosis in the United States. Mult. Scler. 4, 419\u2013425 (1998)","journal-title":"Mult. Scler."},{"key":"537_CR69","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1600-0404.1997.tb00208.x","volume":"95","author":"CV Asche","year":"1997","unstructured":"Asche, C.V., Ho, E., Chan, B., Coyte, P.C.: Economic consequences of multiple sclerosis for Canadians. Acta Neurol. Scand. 95, 268\u2013274 (1997)","journal-title":"Acta Neurol. Scand."},{"key":"537_CR70","first-page":"23","volume":"3","author":"ST Fleming","year":"1995","unstructured":"Fleming, S.T.: Multiple sclerosis as a comorbidity: a study of resource utilization and outcomes of care. Clin. Perform. Qual. Health Care. 3, 23\u201330 (1995)","journal-title":"Clin. Perform. Qual. Health Care."},{"key":"537_CR71","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1359105305048562","volume":"10","author":"MP McCabew","year":"2005","unstructured":"McCabew, M.P., De Judicibus, M.: The effects of economic disadvantage on psychological well-being and quality of life among people with multiple sclerosis. J. Health Psychol. 10, 163\u2013173 (2005)","journal-title":"J. Health Psychol."},{"key":"537_CR72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004356-199209000-00004","volume":"15","author":"M Catanzaro","year":"1992","unstructured":"Catanzaro, M., Weinert, C.: Economic status of families living with multiple sclerosis. Int. J. Rehabil. Res. 15, 209\u2013218 (1992)","journal-title":"Int. J. Rehabil. Res."},{"key":"537_CR73","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3111\/13696998.2010.525989","volume":"13","author":"A Wundes","year":"2010","unstructured":"Wundes, A., Brown, T., Bienen, E.J., Coleman, C.I.: Contribution of intangible costs to the economic burden of multiple sclerosis. J. Med. Econ. 13, 626\u2013632 (2010)","journal-title":"J. Med. Econ."},{"key":"537_CR74","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-0404.2011.01526.x","volume":"125","author":"RA Marrie","year":"2012","unstructured":"Marrie, R.A., Horwitz, R., Cutter, G., Tyry, T.: Cumulative impact of comorbidity on quality of life in MS. Acta Neurol. Scand. 125, 180\u2013186 (2012)","journal-title":"Acta Neurol. Scand."},{"key":"537_CR75","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0028-3843(14)60295-4","volume":"44","author":"K Jaracz","year":"2010","unstructured":"Jaracz, K., Pawlak, M., G\u00f3rna, K., Ko\u0142cz, B., Wo\u0142oszyn, D., Kozubski, W.: Quality of life and social support in patients with multiple sclerosis. Neurol. Neurochir. Pol. 44, 358\u2013365 (2010)","journal-title":"Neurol. Neurochir. Pol."},{"key":"537_CR76","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/1352458509345917","volume":"15","author":"J Rivera-Navarro","year":"2009","unstructured":"Rivera-Navarro, J., Benito-Le\u00f3n, J., Oreja-Guevara, C., Pardo, J., Dib, W.B., Orts, E., Bell\u00f3, M.: Caregiver Quality of Life in Multiple Sclerosis (CAREQOL-MS) Study Group. Burden and health-related quality of life of Spanish caregivers of persons with multiple sclerosis. Mult. Scler. 15, 1347\u20131355 (2009)","journal-title":"Mult. Scler."}],"container-title":["The European Journal of Health Economics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-013-0537-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10198-013-0537-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10198-013-0537-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T03:52:03Z","timestamp":1647575523000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10198-013-0537-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,1]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1007\/s10198-013-0537-5","relation":{},"ISSN":["1618-7598","1618-7601"],"issn-type":[{"value":"1618-7598","type":"print"},{"value":"1618-7601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,1]]}}}